App aims to ease bladder leakage in women without surgery
NCT ID NCT06389838
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a smartphone app designed to help women with urinary incontinence reduce leakage episodes and improve quality of life. About 194 women used the app or received standard care for 12 weeks. The goal was to see if the app could cut incontinence episodes in half.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
194 people
The number who actually took part.
- Started
-
Apr 2024
- Finished
-
Dec 2024
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women aged 18 years or older. * Diagnosis of urinary incontinence, including stress incontinence, urge incontinence, or mixed incontinence. * Mastery of the German language. * Access to the internet. * Access to a tablet or smartphone (Android not older than version 7 and iPhone not older than iPhone 9). * Ability to provide informed consent Exclusion Criteria: * Acute cystitis (N30.0) * Bladder stones (N21.0) * Recurrent, uncontrollable macrohematuria (R31) * Newly diagnosed bladder carcinoma \< 3 months (C67) * Relative Exclusion Criteria not coded according to ICD-10: * Inability to physically participate in the therapy program * Active pregnancy * Bladder botulinum toxin treatment within the last 6 months * Study-specific methodological exclusion criteria: * Patients unable to understand and independently sign the consent form * Initiation of new medication or physical therapy for urinary symptoms within the last 4 weeks * Severe psychiatric disorders hindering app usage * Neurological disorders affecting the urinary tract * Incontinence or tumor surgeries in the pelvic area * Severe obesity (BMI \>35) * Recurrent urinary tract infections (at least 2 within 6 months or 3 within a year)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Female urinary stress incontinence are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinic of Urology
Mainz, Germany, 55131, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Estrogen drop may hold clue to bladder leaks in women with spinal cord injury
- Bladder leaks may signal frailty in older adults
- A gentler catheter may cut infection risk for women in hospitals
- Can a Full-Body rehab program help children stop wetting?
- A gentle nerve zap may calm an overactive bladder
- Magnetic chair therapy aims to strengthen pelvic floor without surgery